Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era.

H.W. Löms Ziegler-Heitbrock, Eckhard Thiel, Recombinant IFN-α in Lymphomas Journal of Investigative Dermatology. ,vol. 95, pp. S213- S215 ,(1990) , 10.1111/1523-1747.EP12875789

Kenneth A. Foon, Biological response modifiers: the new immunotherapy. Cancer Research. ,vol. 49, pp. 1621- 1639 ,(1989)

GABRIEL G. VEGA, LUZ ARELI FRANCO-CEA, SARA HUERTA-YEPEZ, HÉCTOR MAYANI, SHERIE L. MORRISON, BENJAMIN BONAVIDA, MARIO I. VEGA, Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy. International Journal of Oncology. ,vol. 47, pp. 1735- 1748 ,(2015) , 10.3892/IJO.2015.3170

Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach, Hareth Nahi, Peter Gimsing, Markus Hansson, Monique C. Minnema, Ulrik Lassen, Jakub Krejcik, Antonio Palumbo, Niels W.C.J. van de Donk, Tahamtan Ahmadi, Imran Khan, Clarissa M. Uhlar, Jianping Wang, A. Kate Sasser, Nedjad Losic, Steen Lisby, Linda Basse, Nikolai Brun, Paul G. Richardson, Targeting CD38 with daratumumab monotherapy in multiple myeloma The New England Journal of Medicine. ,vol. 373, pp. 1207- 1219 ,(2015) , 10.1056/NEJMOA1506348

H Jiang, C Acharya, G An, M Zhong, X Feng, L Wang, N Dasilva, Z Song, G Yang, F Adrian, L Qiu, P Richardson, N C Munshi, Y-T Tai, K C Anderson, SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide. Leukemia. ,vol. 30, pp. 399- 408 ,(2016) , 10.1038/LEU.2015.240

S A Rosenberg, R B Cameron, A Eisenthal, Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody. Journal of Immunology. ,vol. 144, pp. 4463- 4471 ,(1990)

Seigo Terawaki, Shunsuke Chikuma, Shiro Shibayama, Tamon Hayashi, Takao Yoshida, Taku Okazaki, Tasuku Honjo, IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity Journal of Immunology. ,vol. 186, pp. 2772- 2779 ,(2011) , 10.4049/JIMMUNOL.1003208

Güllü Görgün, Mehmet K. Samur, Kristen B. Cowens, Steven Paula, Giada Bianchi, Julie E. Anderson, Randie E. White, Ahaana Singh, Hiroto Ohguchi, Rikio Suzuki, Shohei Kikuchi, Takeshi Harada, Teru Hideshima, Yu-Tzu Tai, Jacob P. Laubach, Noopur Raje, Florence Magrangeas, Stephane Minvielle, Herve Avet-Loiseau, Nikhil C. Munshi, David M. Dorfman, Paul G. Richardson, Kenneth C. Anderson, Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma Clinical Cancer Research. ,vol. 21, pp. 4607- 4618 ,(2015) , 10.1158/1078-0432.CCR-15-0200

Denis Puthier, Wilfrid Thabard, Marie-José Rapp, Marguerite Etrillard, Jean-Luc Harousseau, Régis Bataille, Martine Amiot, Interferon α extends the survival of human myeloma cells through an upregulation of the Mcl‐1 anti‐apoptotic molecule British Journal of Haematology. ,vol. 112, pp. 358- 363 ,(2001) , 10.1046/J.1365-2141.2001.02575.X

Paul Shinn, Rajarshi Guha, Marc Ferrer, Craig Thomas, Thomas A. Waldmann, Louis M. Staudt, Yibin Yang, Arthur L. Shaffer, N.C. Tolga Emre, Michele Ceribelli, Meili Zhang, George Wright, Wenming Xiao, John Powell, John Platig, Holger Kohlhammer, Ryan M. Young, Hong Zhao, Yandan Yang, Weihong Xu, Joseph J. Buggy, Sriram Balasubramanian, Lesley A. Mathews, Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma Cancer Cell. ,vol. 21, pp. 723- 737 ,(2012) , 10.1016/J.CCR.2012.05.024